Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis

Hepatology

Volumn 43, Issue 6, 2006, Pages 1267-1275

  Fujii, Tsutomu ^a   Nomoto, Shuji ^a   Koshikawa, Katsumi ^a   Yatabe, Yasushi ^b   Teshigawara, Osamu ^a   Mori, Toshiaki ^a   Inoue, Soichiro ^a   Takeda, Shin ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA ACTIN; FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL LINE; CHROMATID; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; ONCOGENE; PITUITARY TUMOR TRANSFORMING GENE 1; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, NEOPLASM; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TISSUE CULTURE TECHNIQUES; TUMOR MARKERS, BIOLOGICAL;

EID: 33745558607     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21181     Document Type: Article

References (33)

1. Arii S, Okamoto E, Imamura M. Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol 1996;12:204-211.
2. Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998;4:1475-1482.
3. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470.
4. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, et al. Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nat Genet 1996;14:457-460.
5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
6. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
7. Pei L, Melmed S. Isoration and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997;11:433-441.
8. Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M, et al. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms: evidence for a transcriptional activation function of hPTTG. Oncogene 1998;17:2187-2193.
9. Zou H, McGarry TJ, Bernal T, Kirschner MW. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 1999;285:418-422.
10. Yu R, Ren SG, Horwitz GA, Wang Z, Melmed S. Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. Mol Endocrinol 2000;14:1137-1146.
11. Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM, et al. Securin is required for chromosomal stability in human cells. Cell 2001;105:445-457.
12. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F, et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 2002;32:306-311.
13. Zhou Y, Mehta KR, Choi AP, Scolavino S, Zhang X. DNA damage-induced inhibition of securing expression is mediated by p53. J Biol Chem 2003;278:462-470.
14. Zhang X, Horwitz G, Prezant TR, Valentinii A, Nakashima M, Bronstein MD, et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1999;13:156-166.
15. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 2002;87:4238-4244.
16. Ishikawa H, Heaney AP, Yu R, Horwitz GA, Melmed S. Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 2001;86:867-874.
17. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 4th ed. Tokyo: Kanehara 2000.
18. Lau H, Fan ST, Ng IO, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998;83:2302-2311.
19. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. HEPATOLOGY 1991;14:802-805.
20. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. HEPATOLOGY 1992;16:1367-1371.
21. Yoshiji H, Kuriyama S, Yoshiji J, Ikenaka Y, Noguchi R, Hicklin DJ, et al. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. HEPATOLOGY 2002;35:834-842.
22. Imura S, Miyake H, Izumi K, Tashiro S, Uehara H. Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma. J Med Invest 2004;51:202-209.
23. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999;5:1317-1321.
24. Auner HW, Zebisch A, Schimek MG, Bodner C, Hiden K, Linkesch W, et al. High expression of the sister-chromatid separation regulator and protooncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidy. Leukemia 2004;18:303-308.
25. Boelaert K, McCabe CJ, Tannahill LA, Gittoes NJ, Holder RL, Watkinson JC, et al. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indications in differentiated thyroid cancer. J Clin Endocrinol Metab 2003;88:2341-2347.
26. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashiima M, Melmed S. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 2000;355:716-719.
27. Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N, et al. Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol 2002;32:233-237.
28. Solbach C, Roller M, Fellbaum C, Nicoletti M, Kaufmann M. PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast 2004;13:80-81.
29. Wen CY, Nakayama T, Wang AP, Nakashima M, Ding YT, Ito M, et al. Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol 2004;10:481-483.
30. Kim DS, Franklyn JA, Stratford AL, Boelaert K, Watkinson JC, Eggo MC, et al. Pituitary tumor transforming gene (PTTG) regulates multiple downstream angiogenic genes in thyroid cancer. J Clin Endocrinol Metab 2006;91:1119-1128.
31. Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan ST, et al. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 2002;20:1775-1785.
32. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. HEPATOLOGY 1998;27:1554-1562.
33. Tanigawa N, Lu C, Mitsui T, Miura S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. HEPATOLOGY 1997;26:1216-1223.